# Contact Medicinal TB-500: Editorial Corrections and Source Notes

> Contact Medicinal TB-500 — an editorial research board on the thymosin beta-4 peptide. Reach the editors with corrections, source suggestions, or citation queries. Not a clinic; no medical or purchasing inquiries.

For corrections, source suggestions, and citation queries about the TB-500 research board. We are an editorial project, not a clinic or a vendor.

## How to reach the editors

Medicinal TB-500 is an editorial research board on the thymosin beta-4 peptide. The most useful messages we receive concern the record itself: a citation that needs correcting, a study we should add, a place where a finding on full-length thymosin beta-4 has been read too loosely as a TB-500 result, or a regulatory update that supersedes what is on the legal-status page. Use the form below and point us to the source.

We read every note about accuracy. If you flag a claim, include the page, the specific sentence, and the citation or document that supports your correction. That is the fastest way to get the board fixed.

## What we cannot help with

We cannot answer medical questions, advise on personal use, or suggest doses — we are not clinicians and the site does not provide medical advice. We do not sell, supply, source, or price TB-500 or any other substance, and we cannot point you to anyone who does; purchasing and sourcing inquiries will not receive a reply.

For anything about the regulatory standing of the peptide, the [TB-500 legal status](/legal-status) page is the reference, drawn from primary FDA sources and framed as general information rather than legal advice. For the science, the research and references pages carry the cited record.

---

The TB-500 record sorted onto one flat status board — each study dropped into its evidence row, the Ac-LKKTETQ fragment kept apart from its parent protein thymosin beta-4, and the empty human-trial row left in plain sight; no clinic stands behind the board and nothing here is dispensed or sold.